Antibacterial (Drug) Resistance Market – Global Outlook and Forecast 2022-2028

Antibacterial drug resistance is the process that bacteria use to tolerate and overcome the effects of antibiotic drugs. Resistance can arise through mutations or can be acquired from other bacteria through plasmids.

This report contains market size and forecasts of Antibacterial (Drug) Resistance in global, including the following market information:

Global Antibacterial (Drug) Resistance Market Revenue, 2017-2022, 2023-2028, ($ millions)

Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/7164737/global-antibacterial-resistance-2022-2028-626

Global Antibacterial (Drug) Resistance Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Antibacterial (Drug) Resistance companies in 2021 (%)

The global Antibacterial (Drug) Resistance market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Telavancin (Vibativ) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antibacterial (Drug) Resistance include Melinta Therapeutics, Allergan, Merck, Abbott Laboratories, Pfizer, GSK, PENDOPHARM, Absynth Biologics and Achaogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antibacterial (Drug) Resistance manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibacterial (Drug) Resistance Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antibacterial (Drug) Resistance Market Segment Percentages, by Type, 2021 (%)

Telavancin (Vibativ)

Ceftaroline Fosamil (Teflaro/ Zinforo)

Fidaxomicin (Dificid / Dificlir)

Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)

Dalbavancin (Dalvance/ Xydalba)

Tedizolid Phosphate (Sivextro)

Oritavancin (Orbactiv/ Nuvocid)

Ceftolozane-Tazobactam (Zerbaxa)

Ceftazidime-Avibactam (Avycaz/ Zavicefta)

PHASE III DRUGS

Global Antibacterial (Drug) Resistance Market, by Indication, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antibacterial (Drug) Resistance Market Segment Percentages, by Indication, 2021 (%)

Complicated Urinary Tract Infection (CUTI)

Complicated Intra-Abdominal Infections (CIAI)

Blood Stream Infections (BSI)

Clostridium Difficile Infections (CDI)

Acute Bacterial Skin And Skin Structure Infections (ABSSSI)

Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)

Community Acquired Bacterial Pneumonia (CABP)

Global Antibacterial (Drug) Resistance Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antibacterial (Drug) Resistance Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibacterial (Drug) Resistance revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Antibacterial (Drug) Resistance revenues share in global market, 2021 (%)

Key companies Antibacterial (Drug) Resistance sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Antibacterial (Drug) Resistance sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Melinta Therapeutics

Allergan

Merck

Abbott Laboratories

Pfizer

GSK

PENDOPHARM

Absynth Biologics

Achaogen

Acino Holdings

Aventis Pharma

Austell Laboratories

Assembly Biosciences

Arpida

Demuris

Evolva Holding

ContraFect

Cerexa

InterMune

Isis Pharmaceuticals

Lyndra

Microbecide

Morphochem

Nabriva Therapeutics

NanoSafe Coatings

Novexel

Osel

VenatoRx Pharmaceuticals

AAIPharma Services

ANTABIO

Table of content

1 Introduction to Research & Analysis Reports
1.1 Antibacterial (Drug) Resistance Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Indication
1.3 Global Antibacterial (Drug) Resistance Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibacterial (Drug) Resistance Overall Market Size
2.1 Global Antibacterial (Drug) Resistance Market Size: 2021 VS 2028
2.2 Global Antibacterial (Drug) Resistance Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antibacterial (Drug) Resistance Sales: 2017-2028
3 Company Landscape
3.1 Top Antibacterial (Drug) Resistance Players in Global Market
3.2 Top Global Antibacterial (Drug) Resistance Companies Ranked by Revenue
3.3 Global Antibacterial (Drug) Resistance Revenue by Companies
3.4 Global Antibacterial (Drug) Resistance Sales by Companies
3.5 Global Antibacterial (Drug) Resistance Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antibacterial (Drug) Resistance Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antibacterial (Drug) Resistance Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibacterial (Drug) Resistance Players in Global Market
3.8.1 List of Global Tier 1 Antibacterial (Drug) Resi

 

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Visit: https://www.statsmarketresearch.com/
Similar Reports: Antibacterial (Drug) Resistance Market – Global Outlook and Forecast 2021-2027

Global and United States Antibacterial (Drug) Resistance Market Insights, Forecast to 2027

Global Antibacterial (Drug) Resistance Market Research Report 2021
 

Previous post Fieldbus Solutions for Process Market – Global Outlook and Forecast 2022-2028
Next post Insulated Shipping Container Market – Global Outlook and Forecast 2022-2028